Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

RFQ forms for metro rail to be sold from July 24
Hyderabad Metro Rail Limited (HMRL), the special purpose vehicle set up to implement the metro rail project in the city, had postponed the sale of Request for Qualification (RFQ) applications for global bids to July 24, according to municipal administration and urban development principal secretary and Hyderabad metro rail project chairman CVSK Sarma.

HCL Infosystems Q2 net down 11% to Rs 59 cr
IT firm HCL Infosystems today reported a consolidated net profit of Rs 58.97 crore for the second quarter ended September 2009, a 10.77 per cent drop over the same period a year ago.

News of the day

Mulayam plays down Amar resignation as 'nothing big'
A day after senior Samajwadi Party leader Amar Singh announced his resignation from key posts, party supremo and former Uttar Pradesh chief minister Mulayam Singh Yadav today said Amar Singh continued to be in the party fold and his quitting key posts was “nothing big”.
Public Company

Ranbaxy, Aurobindo get USFDA nod for migraine drug

Pharma majors Ranbaxy and Aurobindo Pharma today said that they have received final approval from the US Food and Drug Administration(USFDA) to manufacture and market Sumatripan Succinate. - Ranbaxy Malaysia launches one-day generic Losartan K 50mg and 100mg tablet - Ranbaxy to set up drug making unit - Daiichi Sankyo posts Q1 loss of 6.43 bn yen - Lunch with BS: Malvinder Mohan Singh">Lunch with BS: Malvinder Mohan Singh - HC rejects plea seeking to quash Sebi Zenotech order - Ranbaxy's Q2 net soars 30-fold While Ranbaxy got approval for 25 and 50 mg varients of the drug, Aurobindo got the approval for 100 mg tablets apart from 25 and 50 mg tablets. The Office of Generic Drugs, USFDA, has determined the Ranbaxy formulations to be bio-equivalent and have the same therapeutic effect that of the reference listed drug Imitrex manufactured by GlaxoSmithkilne. The drug is used in the treatment of migraine in adults. Ranbaxy shares were trading at Rs 275.25, nearly 14.25 per cent higher than Monday"s close. Aurobindo stock was trading at Rs 615.05, nearly 3.35 per cent down from Monday"s close.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009